<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37005464</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry.</ArticleTitle><Pagination><StartPage>5339</StartPage><MedlinePgn>5339</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5339</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-32569-6</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a multi-organ autoimmune disorder with a prominent genetic component. Individuals of Asian-Ancestry (AsA) disproportionately experience more severe SLE compared to individuals of European-Ancestry (EA), including increased renal involvement and tissue damage. However, the mechanisms underlying elevated severity in the AsA population remain unclear. Here, we utilized available gene expression data and genotype data based on all non-HLA SNP associations in EA and AsA SLE patients detected using the Immunochip genotyping array. We identified 2778 ancestry-specific and 327 trans-ancestry SLE-risk polymorphisms. Genetic associations were examined using connectivity mapping and gene signatures based on predicted biological pathways and were used to interrogate gene expression datasets. SLE-associated pathways in AsA patients included elevated oxidative stress, altered metabolism and mitochondrial dysfunction, whereas SLE-associated pathways in EA patients included a robust interferon response (type I and II) related to enhanced cytosolic nucleic acid sensing and signaling. An independent dataset derived from summary genome-wide association data in an AsA cohort was interrogated and identified similar molecular pathways. Finally, gene expression data from AsA SLE patients corroborated the molecular pathways predicted by SNP associations. Identifying ancestry-related molecular pathways predicted by genetic SLE risk may help to disentangle the population differences in clinical severity that impact AsA and EA individuals with SLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC and the RILITE Research Institute, Charlottesville, VA, 22902, USA. kate.owen@ampelbiosolutions.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Kristy A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC and the RILITE Research Institute, Charlottesville, VA, 22902, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC and the RILITE Research Institute, Charlottesville, VA, 22902, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachali</LastName><ForeName>Prathyusha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC and the RILITE Research Institute, Charlottesville, VA, 22902, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainsworth</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science, Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marion</LastName><ForeName>Miranda C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science, Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Timothy D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langefeld</LastName><ForeName>Carl D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science, Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazdany</LastName><ForeName>Jinoos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of California San Francisco, San Francisco, CA, 94117, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dall'era</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of California San Francisco, San Francisco, CA, 94117, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grammer</LastName><ForeName>Amrie C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC and the RILITE Research Institute, Charlottesville, VA, 22902, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipsky</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC and the RILITE Research Institute, Charlottesville, VA, 22902, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 DP006486</GrantID><Acronym>DP</Acronym><Agency>NCCDPHP CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37005464</ArticleId><ArticleId IdType="pmc">PMC10067935</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-32569-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-32569-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li PH, Lau CS. Lupus in the far East: A modern epidemic. Int. J. Rheum. Dis. 2017;20:523&#x2013;525. doi: 10.1111/1756-185X.13115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13115</ArticleId><ArticleId IdType="pubmed">28597499</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus. 2013;22:1192&#x2013;1199. doi: 10.1177/0961203313499086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313499086</ArticleId><ArticleId IdType="pubmed">23963101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DYH, Chan TM. Lupus nephritis in Asia: Clinical features and management. Kidney Dis. 2015;1:100&#x2013;109. doi: 10.1159/000430458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000430458</ArticleId><ArticleId IdType="pmc">PMC4934808</ArticleId><ArticleId IdType="pubmed">27536670</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanata CM, et al. Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients. PLoS ONE. 2018;13:e0199003. doi: 10.1371/journal.pone.0199003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0199003</ArticleId><ArticleId IdType="pmc">PMC6023154</ArticleId><ArticleId IdType="pubmed">29953444</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok MY, Li WL. Do Asian patients have worse lupus? Lupus. 2010;19:1384&#x2013;1390. doi: 10.1177/0961203310375832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310375832</ArticleId><ArticleId IdType="pubmed">20947546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat. Genet. 2016;48:323&#x2013;330. doi: 10.1038/ng.3496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3496</ArticleId><ArticleId IdType="pmc">PMC4767573</ArticleId><ArticleId IdType="pubmed">26808113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessard CJ, et al. Identification of a systemic lupus erythematosus risk locus spanning ATG16L2, FCHSD2, and P2RY2 in Koreans. Arthritis Rheumatol. 2016;68:1197&#x2013;1209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4981330</ArticleId><ArticleId IdType="pubmed">26663301</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 2017;8:16021. doi: 10.1038/ncomms16021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16021</ArticleId><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nat. Genet. 2016;48:940&#x2013;946. doi: 10.1038/ng.3603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3603</ArticleId><ArticleId IdType="pmc">PMC4966635</ArticleId><ArticleId IdType="pubmed">27399966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 2015 doi: 10.1038/ng.3434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3434</ArticleId><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen KA, et al. Analysis of trans-ancestral SLE risk loci identifies unique biologic networks and drug targets in African and European Ancestries. Am. J. Hum. Genet. 2020;107:864&#x2013;881. doi: 10.1016/j.ajhg.2020.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2020.09.007</ArticleId><ArticleId IdType="pmc">PMC7675009</ArticleId><ArticleId IdType="pubmed">33031749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain J, et al. Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease. Cell Rep. Med. 2022;3:100805. doi: 10.1016/j.xcrm.2022.100805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100805</ArticleId><ArticleId IdType="pmc">PMC9729823</ArticleId><ArticleId IdType="pubmed">36334592</ArticleId></ArticleIdList></Reference><Reference><Citation>Westra HJ, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 2013;45:1238&#x2013;1243. doi: 10.1038/ng.2756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2756</ArticleId><ArticleId IdType="pmc">PMC3991562</ArticleId><ArticleId IdType="pubmed">24013639</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishilevich, S. et al. GeneHancer: Genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford).2017, bax028 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467550</ArticleId><ArticleId IdType="pubmed">28605766</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. HACER: An atlas of human active enhancers to interpret regulatory variants. Nucleic Acids Res. 2019;47:D106&#x2013;D112. doi: 10.1093/nar/gky864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky864</ArticleId><ArticleId IdType="pmc">PMC6323890</ArticleId><ArticleId IdType="pubmed">30247654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingsmore KM, et al. Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus. Sci. Rep. 2021;11:14789. doi: 10.1038/s41598-021-93034-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93034-w</ArticleId><ArticleId IdType="pmc">PMC8292402</ArticleId><ArticleId IdType="pubmed">34285256</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 2011;13:101. doi: 10.1186/ar3204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3204</ArticleId><ArticleId IdType="pmc">PMC3157635</ArticleId><ArticleId IdType="pubmed">21345260</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, et al. Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat. Immunol. 2021;22:1107&#x2013;1117. doi: 10.1038/s41590-021-00993-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00993-3</ArticleId><ArticleId IdType="pmc">PMC8609402</ArticleId><ArticleId IdType="pubmed">34385713</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann, S., Castelo, R. &amp; Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 14, 7 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lightfoot YL, Blanco LP, Kaplan MJ. Metabolic abnormalities and oxidative stress in lupus. Curr. Opin. Rheumatol. 2017;29:442&#x2013;449. doi: 10.1097/BOR.0000000000000413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000413</ArticleId><ArticleId IdType="pmc">PMC5586499</ArticleId><ArticleId IdType="pubmed">28639951</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreoletti, G. et al. Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures. Commun. Biol.4, 488 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060402</ArticleId><ArticleId IdType="pubmed">33883687</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah D, Mahajan N, Sah S, Nath SK, Paudyal B. Oxidative stress and its biomarkers in systemic lupus erythematosus. J. Biomed. Sci. 2014;21:23. doi: 10.1186/1423-0127-21-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-23</ArticleId><ArticleId IdType="pmc">PMC3995422</ArticleId><ArticleId IdType="pubmed">24636579</ArticleId></ArticleIdList></Reference><Reference><Citation>Namas, R., Renauer, P., Ognenovski, M., Tsou, P. S. &amp; Sawalha, A. H. Histone H2AX phosphorylation as a measure of DNA double-strand breaks and a marker of environmental stress and disease activity in lupus. Lupus Sci. Med.3, e000148 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854117</ArticleId><ArticleId IdType="pubmed">27158526</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages. J. Transl. Med.14, 156 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888250</ArticleId><ArticleId IdType="pubmed">27250627</ArticleId></ArticleIdList></Reference><Reference><Citation>Giles BM, Boackle SA. Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus. Immunol. Res. 2013;55:10. doi: 10.1007/s12026-012-8345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-012-8345-z</ArticleId><ArticleId IdType="pmc">PMC4018221</ArticleId><ArticleId IdType="pubmed">22941560</ArticleId></ArticleIdList></Reference><Reference><Citation>Caielli S, et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell. 2021;184:4464&#x2013;4479.e19. doi: 10.1016/j.cell.2021.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.07.021</ArticleId><ArticleId IdType="pmc">PMC8380737</ArticleId><ArticleId IdType="pubmed">34384544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford) 2017;56:i67&#x2013;i77.</Citation><ArticleIdList><ArticleId IdType="pubmed">27940583</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman CH, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000&#x2013;2004. Arthritis Rheum. 2013;65:753&#x2013;763. doi: 10.1002/art.37795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37795</ArticleId><ArticleId IdType="pmc">PMC3733212</ArticleId><ArticleId IdType="pubmed">23203603</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson EK, Covarrubias S, Carpenter S. The how and why of lncRNA function: An innate immune perspective. Biochimica et Biophysica Acta Gene Regulat. Mech. 2020;1863:194419. doi: 10.1016/j.bbagrm.2019.194419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2019.194419</ArticleId><ArticleId IdType="pmc">PMC7185634</ArticleId><ArticleId IdType="pubmed">31487549</ArticleId></ArticleIdList></Reference><Reference><Citation>Riege, K. et al. Massive effect on LncRNAs in human monocytes during fungal and bacterial infections and in response to vitamins A and D. Sci. Rep.7, 40598 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5240112</ArticleId><ArticleId IdType="pubmed">28094339</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein N, et al. IFNG-AS1 enhances interferon gamma production in human natural killer cells. iScience. 2019;11:466&#x2013;473. doi: 10.1016/j.isci.2018.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2018.12.034</ArticleId><ArticleId IdType="pmc">PMC6354656</ArticleId><ArticleId IdType="pubmed">30661002</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R, Ahmed SA. microRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 2011;157:163. doi: 10.1016/j.trsl.2011.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2011.01.007</ArticleId><ArticleId IdType="pmc">PMC3072681</ArticleId><ArticleId IdType="pubmed">21420027</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai, C-Y. et al. Cross-talk between mitochondrial dysfunction-provoked oxidative stress and aberrant noncoding RNA expression in the pathogenesis and pathophysiology of SLE. Int. J. Mol. Sci.20, 5183 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6829370</ArticleId><ArticleId IdType="pubmed">31635056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C-Y, et al. Aberrant non-coding RNA expression in patients with systemic lupus erythematosus: Consequences for immune dysfunctions and tissue damage. Biomolecules. 2020;10:1&#x2013;24. doi: 10.3390/biom10121641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10121641</ArticleId><ArticleId IdType="pmc">PMC7762297</ArticleId><ArticleId IdType="pubmed">33291347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Long noncoding RNAs in the regulation of oxidative stress. Oxid. Med. Cell. Longev.2019, 1318795 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398004</ArticleId><ArticleId IdType="pubmed">30911342</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalina, M. D. et al. Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus. JCI Insight. 5, e140380 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455079</ArticleId><ArticleId IdType="pubmed">32759501</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y-F. et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat. Commun.12, 772 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Griss, J. et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat. Commun.10, 4186 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6744450</ArticleId><ArticleId IdType="pubmed">31519915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nossent, J. C., Becker-Merok, A., Rischmueller, M. &amp; Lester, S. Susceptibility for lupus nephritis by low copy number of the FCGR3B gene is linked to increased levels of pathogenic autoantibodies. Autoimmune Dis.2013, 750814 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3705838</ArticleId><ArticleId IdType="pubmed">23864940</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau R, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165:551&#x2013;565. doi: 10.1016/j.cell.2016.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.03.008</ArticleId><ArticleId IdType="pmc">PMC5426482</ArticleId><ArticleId IdType="pubmed">27040498</ArticleId></ArticleIdList></Reference><Reference><Citation>Menard, L. C. et al. B cells from African American lupus patients exhibit an activated phenotype. JCI Insight1, e87310 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5033941</ArticleId><ArticleId IdType="pubmed">27699274</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz CSD, Kang M-J. Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases. Mitochondrion. 2018;41:37. doi: 10.1016/j.mito.2017.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.12.001</ArticleId><ArticleId IdType="pmc">PMC5988941</ArticleId><ArticleId IdType="pubmed">29221810</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskiewicz IA, et al. Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. Sci. Signal. 2016;9:ra115. doi: 10.1126/scisignal.aaf1933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aaf1933</ArticleId><ArticleId IdType="pmc">PMC5321043</ArticleId><ArticleId IdType="pubmed">27899525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. Oxidant mechanisms in renal injury and disease. Antioxid. Redox Signal. 2016;25:119. doi: 10.1089/ars.2016.6665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2016.6665</ArticleId><ArticleId IdType="pmc">PMC4948213</ArticleId><ArticleId IdType="pubmed">26906267</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakes RW, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64:159&#x2013;168. doi: 10.1002/acr.20683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20683</ArticleId><ArticleId IdType="pubmed">22052624</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman IB, et al. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum. 2012;64:3374&#x2013;3382. doi: 10.1002/art.34567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34567</ArticleId><ArticleId IdType="pmc">PMC3865923</ArticleId><ArticleId IdType="pubmed">23023776</ArticleId></ArticleIdList></Reference><Reference><Citation>Honarpisheh, M., K&#xf6;hler, P., Rauchhaupt, E. von &amp; Lech, M. The involvement of microRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis. J. Immunol. Res.2018, 4126106 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964414</ArticleId><ArticleId IdType="pubmed">29854836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Wang H, Yin L, Mao Y, Zhou W. Immunometabolism in the pathogenesis of systemic lupus erythematosus. J. Transl. Autoimmun. 2020;3:100046. doi: 10.1016/j.jtauto.2020.100046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100046</ArticleId><ArticleId IdType="pmc">PMC7388408</ArticleId><ArticleId IdType="pubmed">32743527</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayson PC, et al. Metabolic pathways and immunometabolism in rare kidney diseases. Ann. Rheum. Dis. 2018;77:1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6045442</ArticleId><ArticleId IdType="pubmed">29724730</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez D, Bonilla E, Mirza N, Niland B, Perl A. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum. 2006;54:2983&#x2013;2988. doi: 10.1002/art.22085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22085</ArticleId><ArticleId IdType="pmc">PMC4034146</ArticleId><ArticleId IdType="pubmed">16947529</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Z-W, et al. N-Acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012;64:2937&#x2013;2946. doi: 10.1002/art.34502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34502</ArticleId><ArticleId IdType="pmc">PMC3411859</ArticleId><ArticleId IdType="pubmed">22549432</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Zhang W. Pioglitazone attenuates lupus nephritis symptoms in mice by modulating miR-21-5p/TIMP3 Axis: The key role of the activation of peroxisome proliferator-activated receptor-&#x3b3;. Inflammation. 2021;44:1416&#x2013;1425. doi: 10.1007/s10753-021-01426-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-021-01426-x</ArticleId><ArticleId IdType="pubmed">33604775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward LD, Kellis M. HaploReg v4: Systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44:D877&#x2013;D881. doi: 10.1093/nar/gkv1340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1340</ArticleId><ArticleId IdType="pmc">PMC4702929</ArticleId><ArticleId IdType="pubmed">26657631</ArticleId></ArticleIdList></Reference><Reference><Citation>The Genotype-Tissue Expression (GTEx) project. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010069/. (2013).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010069</ArticleId><ArticleId IdType="pubmed">23715323</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat. Protoc. 2016;11:1&#x2013;9. doi: 10.1038/nprot.2015.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2015.123</ArticleId><ArticleId IdType="pubmed">26633127</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim, N. L. et al. SIFT web server: Predicting effects of amino acid substitutions on proteins. Nucleic Acids Res.40, W452-7 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3394338</ArticleId><ArticleId IdType="pubmed">22689647</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 2013 doi: 10.1002/0471142905.hg0720s76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142905.hg0720s76</ArticleId><ArticleId IdType="pmc">PMC4480630</ArticleId><ArticleId IdType="pubmed">23315928</ArticleId></ArticleIdList></Reference><Reference><Citation>Heberle, H., Meirelles, V. G., da Silva, F. R., Telles, G. P. &amp; Minghim, R. InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 16, 169 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4455604</ArticleId><ArticleId IdType="pubmed">25994840</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai, M. et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res.33, e175 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1283542</ArticleId><ArticleId IdType="pubmed">16284200</ArticleId></ArticleIdList></Reference><Reference><Citation>Labonte AC, et al. Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus. PLoS ONE. 2018;13:e0208132. doi: 10.1371/journal.pone.0208132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208132</ArticleId><ArticleId IdType="pmc">PMC6298676</ArticleId><ArticleId IdType="pubmed">30562343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587&#x2013;D592. doi: 10.1093/nar/gkac963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac963</ArticleId><ArticleId IdType="pmc">PMC9825424</ArticleId><ArticleId IdType="pubmed">36300620</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalina, M. D., Bachali, P., Geraci, N. S., Grammer, A. C. &amp; Lipsky, P. E. Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus. Commun. Biol.2, 140 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6478921</ArticleId><ArticleId IdType="pubmed">31044165</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalina MD, Owen KA, Labonte AC, Grammer AC, Lipsky PE. The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus. J. Autoimmun. 2019 doi: 10.1016/j.jaut.2019.102359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102359</ArticleId><ArticleId IdType="pubmed">31806421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, et al. Selective histone deacetylase 6 inhibition normalizes B cell activation and Germinal Center Formation in a model of systemic lupus erythematosus. Front. Immunol. 2019;10:2512. doi: 10.3389/fimmu.2019.02512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02512</ArticleId><ArticleId IdType="pmc">PMC6823248</ArticleId><ArticleId IdType="pubmed">31708928</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc.1, e90 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152575</ArticleId><ArticleId IdType="pubmed">33780170</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>